RESEARCH INDICATES THAT PACS1 SYNDROME IS CAUSED BY A TOXIC PROTEIN PRODUCED BY THE MUTATED PACS1 GENE. THE CURRENT RESEARCH IS FOCUSED ON APPROACHES TO REMOVE THE TOXIC PROTEIN, WHICH WILL RESTORE CELL FUNCTION AND ALLEVIATE THE SYMPTOMS OF PACS1 SYNDROME.
Dr. GARY THOMAS, Ph.D.
Professor, University of Pittsburgh School of Medicine, focusing on the roles of the PACS proteins in the DNA damage response in PACS1 Syndrome.
Dr. ANGELA GRONENBORN, Ph.D.
Head - Department of Structural Biology, University of Pittsburgh School of Medicine, UPMC Rosalind Franklin Chair
Dr. ALICIA GAMBOA, Ph.D.
Head Dr. Gamboa laboratory, Northwestern University, focused on neurodevelopmental disorders, Assistant Professor, Feinberg School of Medicine, Northwestern University.
Dr. ANNE BERG, Ph.D.
Professor, Northwestern Feinberg School of Medicine, initial founder Pediatric Epilepsy Research Consortium, practice-changing clinical research improving outcomes for children with brain disorders.
DONATE AND MAKE A DIFFERENCE TODAY
$600,000 OF GRANTS FUNDED TO DUKE, UPITT AND NWU